Industry Insider Activity

Drug Manufacturers - General insider activity

Concentrated executive and director transaction evidence across 11 companies, with acquisition/disposal balance, filing cadence, value concentration, and linked company research.

Latest filing 20 Jul 2026 505 filings tracked

Top-level read

Net insider buying

Drug Manufacturers - General shows 302 acquisition filings against 203 disposal filings. The largest stored filing is $26.1M in AMGN by BRADWAY, ROBERT A.

Net value $48.2Macquisitions minus disposals
Companies 11with stored filings
Total filings 505stored transaction rows
Acquisition value $105.6M302 acquisitions
Disposal value $57.4M203 disposals
Largest filing $26.1Mreported transaction value

Filing cadence

Last 12 active months
Mar 2026 118
Apr 2026 118
May 2026 162
Jun 2026 80
Jul 2026 27

Acquisitions 59.8% · Disposals 40.2%

Company Reads

Most active company insider tapes

11 shown

Transaction Evidence

Latest filings in Drug Manufacturers - General

Showing 31-60 of 505
Date 30 Jun 2026
Symbol BMYBristol-Myers Squibb Company
Insider MCMULLEN, MICHAEL R.Director
Side Acquisition
Shares 607
Value 35000
Industry Drug Manufacturers - General
Date 30 Jun 2026
Symbol BMYBristol-Myers Squibb Company
Insider YALE, PHYLLIS RDirector
Side Acquisition
Shares 607
Value 35000
Industry Drug Manufacturers - General
Date 30 Jun 2026
Symbol ABBVAbbVie Inc
Insider RAPP, EDWARD JDirector
Side Acquisition
Shares 134
Value 33720
Industry Drug Manufacturers - General
Date 30 Jun 2026
Symbol MRKMerck & Company Inc
Insider COE, MARY ELLENDirector
Side Acquisition
Shares 233
Value 30000
Industry Drug Manufacturers - General
Date 30 Jun 2026
Symbol MRKMerck & Company Inc
Insider KARSANBHAI, SURENDRALAL LANCADirector
Side Acquisition
Shares 126
Value 16250
Industry Drug Manufacturers - General
Date 30 Jun 2026
Symbol ABBVAbbVie Inc
Insider QUAGGIN, SUSAN EDirector
Side Acquisition
Shares 62
Value 15602
Industry Drug Manufacturers - General
Date 30 Jun 2026
Symbol MRKMerck & Company Inc
Insider SEIDMAN, CHRISTINE EDirector
Side Acquisition
Shares 63
Value 8125
Industry Drug Manufacturers - General
Date 30 Jun 2026
Symbol PFEPfizer Inc
Insider BOURLA, ALBERTDirector, Chairman & CEO
Side Acquisition
Shares 25
Value 602
Industry Drug Manufacturers - General
Date 26 Jun 2026
Symbol AMRNAmarin Corporation PLC
Insider BERG, AARONPresident and CEO
Side Acquisition
Shares 6250
Value -
Industry Drug Manufacturers - General
Date 26 Jun 2026
Symbol AMRNAmarin Corporation PLC
Insider BERG, AARONPresident and CEO
Side Disposal
Shares 3197
Value 52271
Industry Drug Manufacturers - General
Date 26 Jun 2026
Symbol PFEPfizer Inc
Insider NARAYEN, SHANTANUDirector
Side Acquisition
Shares 2058
Value 50000
Industry Drug Manufacturers - General
Date 26 Jun 2026
Symbol PFEPfizer Inc
Insider ECHEVARRIA, JOSEPHDirector
Side Acquisition
Shares 1904
Value 46250
Industry Drug Manufacturers - General
Date 26 Jun 2026
Symbol PFEPfizer Inc
Insider SMITH, JAMES CDirector
Side Acquisition
Shares 1853
Value 45000
Industry Drug Manufacturers - General
Date 26 Jun 2026
Symbol PFEPfizer Inc
Insider QUINCEY, JAMESDirector
Side Acquisition
Shares 1595
Value 38750
Industry Drug Manufacturers - General
Date 26 Jun 2026
Symbol PFEPfizer Inc
Insider BUCKLEY, MORTIMER JDirector
Side Acquisition
Shares 1544
Value 37500
Industry Drug Manufacturers - General
Date 26 Jun 2026
Symbol PFEPfizer Inc
Insider TARAPOREVALA, CYRUSDirector
Side Acquisition
Shares 1544
Value 37500
Industry Drug Manufacturers - General
Date 26 Jun 2026
Symbol AMRNAmarin Corporation PLC
Insider BERG, AARONPresident and CEO
Side Acquisition
Shares 6250
Value 0
Industry Drug Manufacturers - General
Date 15 Jun 2026
Symbol BMYBristol-Myers Squibb Company
Insider HALLER, JULIA ADirector
Side Acquisition
Shares 20460
Value 1099930
Industry Drug Manufacturers - General
Date 15 Jun 2026
Symbol GILDGilead Sciences Inc
Insider DICKINSON, ANDREW DChief Financial Officer
Side Disposal
Shares 3000
Value 376200
Industry Drug Manufacturers - General
Date 15 Jun 2026
Symbol GILDGilead Sciences Inc
Insider MERCIER, JOHANNAChief Comm & Corp Aff Officer
Side Disposal
Shares 1480
Value 182657
Industry Drug Manufacturers - General
Date 15 Jun 2026
Symbol GILDGilead Sciences Inc
Insider MERCIER, JOHANNAChief Comm & Corp Aff Officer
Side Disposal
Shares 1070
Value 132676
Industry Drug Manufacturers - General
Date 15 Jun 2026
Symbol GILDGilead Sciences Inc
Insider MERCIER, JOHANNAChief Comm & Corp Aff Officer
Side Disposal
Shares 450
Value 56430
Industry Drug Manufacturers - General
Date 15 Jun 2026
Symbol LLYEli Lilly and Company
Insider LUCIANO, JUAN RDirector
Side Acquisition
Shares 14
Value 15917
Industry Drug Manufacturers - General
Date 15 Jun 2026
Symbol LLYEli Lilly and Company
Insider ALVAREZ, RALPHDirector
Side Acquisition
Shares 11
Value 12417
Industry Drug Manufacturers - General
Date 15 Jun 2026
Symbol LLYEli Lilly and Company
Insider FYRWALD, J ERIKDirector
Side Acquisition
Shares 9
Value 9917
Industry Drug Manufacturers - General
Date 15 Jun 2026
Symbol LLYEli Lilly and Company
Insider SULZBERGER, GABRIELLEDirector
Side Acquisition
Shares 4
Value 4958
Industry Drug Manufacturers - General
Date 15 Jun 2026
Symbol PFEPfizer Inc
Insider BOURLA, ALBERTDirector, Chairman & CEO
Side Acquisition
Shares 23
Value 598
Industry Drug Manufacturers - General
Date 15 Jun 2026
Symbol BMYBristol-Myers Squibb Company
Insider HALLER, JULIA ADirector
Side Disposal
Shares 20460
Value 0
Industry Drug Manufacturers - General
Date 12 Jun 2026
Symbol OGNOrganon & Co
Insider ESSNER, ROBERTDirector
Side Acquisition
Shares 17857
Value 240000
Industry Drug Manufacturers - General
Date 12 Jun 2026
Symbol OGNOrganon & Co
Insider EZEKOWITZ, ALANDirector
Side Acquisition
Shares 17857
Value 240000
Industry Drug Manufacturers - General